AstraZeneca’s Forxiga recommended for marketing authorization in EU

AstraZeneca’s Forxiga recommended for marketing authorization in EU

Submitted by admin on February 4, 2019 - 9:52am
Source: 
Pharmaceutical Business Review
News Tags: 
EMA
AstraZeneca
Forxiga
type 1 diabetes
CHMP
Headline: 
AstraZeneca’s Forxiga recommended for marketing authorization in EU
snippet: 

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended AstraZeneca’s Forxiga (dapagliflozin) to treat adults with type-1 diabetes (T1D).

Do Not Allow Advertisers to Use My Personal information